Targeting angiogenesis in cancer therapy: lessons learned and paths forward

Although anti-angiogenic agents have transformed certain aspects of cancer therapy, their full potential remains unrealized. Future strategies should focus on personalized approaches aided by predictive biomarkers, and rational combinations to enhance efficacy and reduce resistance.

Authors

Kathrine S Rallis (ORCID: https://orcid.org/0000-0003-1011-3220)

Institutions

Queen Mary University of London (GB)

Publication Details

Journal: Expert Review of Anticancer Therapy
Published: 2025-12-24
DOI: https://doi.org/10.1080/14737140.2025.2599893
Primary Topic: Angiogenesis and VEGF in Cancer
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Targeting angiogenesis in cancer therapy: lessons learned and paths forward

Kathrine S Rallis

Dec 24, 2025

Expert Review of Anticancer Therapy

Angiogenesis and VEGF in Cancer

article

Targeting angiogenesis in cancer therapy: lessons learned and paths forward

Kathrine S Rallis

December 24, 2025article en

Abstract

Expert Review of Anticancer Therapy

Queen Mary University of London (GB)

Openalex Percentile: Top 36%

Angiogenesis and VEGF in Cancer

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Targeting angiogenesis in cancer therapy: lessons learned and paths forward — Kathrine S Rallis · Expert Review of Anticancer Therapy (2025) | TGRS Research Map | TGRS